Vitamin D 관련 고혈압
C 근거 소규모 연구에서의 근거는 제한적이지만, 일부 긍정적인 신호가 존재합니다.Meta-analyses show modest BP reduction (-2-6 mmHg) in deficient populations only. VITAL trial was negative for cardiovascular endpoints. Research suggests benefits may be limited to correcting deficiency.
결론
Meta-analyses show modest BP reduction (-2-6 mmHg) in deficient populations only. VITAL trial was negative for cardiovascular endpoints. Research suggests benefits may be limited to correcting deficiency.
Key Study Findings
대상 집단: Pregnant women with low calcium intake
대상 집단: Patients with ADPKD
대상 집단: Aa referred to our hospitals between 2018 and 2021
Key Statistics
20
연구
30000
참여자
Mixed
등급
Referenced Papers
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
일반적으로 사용되는 용량
- general:
- 600-800 IU/day
- deficiencycorrection:
- 4,000-5,000 IU/day (under medical supervision)
- cardiovascularsupport:
- 1,000-2,000 IU/day
상한량: 4,000 IU/day (100 mcg)
연구에서 사용된 용량
| 용량 | 기간 | 효과 | N |
|---|---|---|---|
| 500 mg daily | -- | Positive | -- |
| Disease-modifying agents (tolvaptan, etc.) | -- | Positive | -- |
| 36% | -- | Mixed | -- |
| not applicable | -- | Neutral | 103 |
| VD 10 nM; LC 250 µM; combined VD+LC | -- | Positive | -- |
권장 복용 시간: With a meal containing fat for better absorption
Safety & Side Effects
보고된 부작용
- ⚠ Hypercalcemia at very high doses (fatigue, nausea, kidney stones)
- ⚠ Constipation
- ⚠ Generally very safe at recommended doses
알려진 상호작용
- ● Thiazide diuretics (may increase hypercalcemia risk)
- ● Statins (theoretical interaction via CYP enzymes)
- ● Corticosteroids (may reduce vitamin D absorption)
- ● Weight loss medications (may reduce absorption of fat-soluble vitamins)
일일 최대 섭취 허용량: 4,000 IU/day (100 mcg)
건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.
Frequently Asked Questions
Does Vitamin D help with 고혈압?
How much Vitamin D should I take for 고혈압?
Are there side effects of Vitamin D?
How strong is the evidence for Vitamin D and 고혈압?
Related Evidence
Vitamin D 다른 건강 상태에 대한 근거
References
- [1] Jiarui Miao et al.. Brain Behav. 2026. Relationship Between Serum Vitamins and Cognitive Impairment in the Elderly: A Study Based on the NHANES Database. doi:10.1002/brb3.71181 PubMed
- [2] Takafumi Ushida et al.. Hypertens Res. 2025. Dietary supplements and prevention of preeclampsia. doi:10.1038/s41440-025-02144-9 PubMed
- [3] Laura Cianfruglia et al.. Biogerontology. 2025. Cytomegalovirus (CMV), oxidative stress, and inflammation: implications for immunosenescence and age-related diseases in the MARK-AGE population. doi:10.1007/s10522-025-10288-x PubMed
- [4] Samantha S Moe et al.. Can Fam Physician. 2025. Top studies of 2024 relevant to primary care: From the PEER team. doi:10.46747/cfp.7105309 PubMed
- [5] Alberto Soto-Moreno et al.. Acta Dermatovenerol Croat. 2025. Cardiovascular Risk and Systemic Inflammation in Alopecia Areata: An Observational Case-control Study. PubMed
- [6] Kitty St Pierre et al.. Cochrane Database Syst Rev. 2024. Interventions for preventing the progression of autosomal dominant polycystic kidney disease. doi:10.1002/14651858.CD010294.pub3 PubMed
- [7] Elham Hamidpour et al.. Health Sci Rep. 2023. Effects of age and sex on the comorbidities of alopecia areata: A cross-sectional hospital-based study. doi:10.1002/hsr2.1444 PubMed
- [8] Ninghao Huang et al.. Nutrients. 2022. Observational and Genetic Associations of Modifiable Risk Factors with Aortic Valve Stenosis: A Prospective Cohort Study of 0.5 Million Participants. doi:10.3390/nu14112273 PubMed
- [9] Mohammad Yazdchi et al.. Curr J Neurol. 2022. Sleep status in multiple sclerosis: Role of vitamin D and body mass index. doi:10.18502/cjn.v21i2.10489 PubMed
- [10] Wan-Jun Yin et al.. Front Nutr. 2022. Sleep patterns modify the association of 25(OH)D with poor cardiovascular health in pregnant women. doi:10.3389/fnut.2022.1013960 PubMed
- [11] Izolde Bouloukaki et al.. Fam Pract. 2022. Vitamin D levels in primary care patients: correlations with clinical, seasonal, and quality-of-life parameters. doi:10.1093/fampra/cmac012 PubMed
- [12] Giulia Marrone et al.. Nutrients. 2021. Vegan Diet Health Benefits in Metabolic Syndrome. doi:10.3390/nu13030817 PubMed
- [13] Sushil K Jain et al.. J Am Coll Nutr. 2021. l-Cysteine Stimulates the Effect of Vitamin D on Inhibition of Oxidative Stress, IL-8, and MCP-1 Secretion in High Glucose Treated … doi:10.1080/07315724.2020.1850371 PubMed
- [14] Tomohiro Bito et al.. Nutrients. 2020. Potential of Chlorella as a Dietary Supplement to Promote Human Health. doi:10.3390/nu12092524 PubMed
- [15] S C Gominak. Med Hypotheses. 2016. Vitamin D deficiency changes the intestinal microbiome reducing B vitamin production in the gut. The resulting lack of pantothenic acid … doi:10.1016/j.mehy.2016.07.007 PubMed
- [16] Katherine L Tucker. Ann N Y Acad Sci. 2016. Nutrient intake, nutritional status, and cognitive function with aging. doi:10.1111/nyas.13062 PubMed
- [17] Tee Wei Siah et al.. Int J Trichology. 2016. Female Pattern Hair Loss: A Retrospective Study in a Tertiary Referral Center. doi:10.4103/0974-7753.188033 PubMed
- [18] S Basit. Br J Biomed Sci. 2013. Vitamin D in health and disease: a literature review. doi:10.1080/09674845.2013.11669951 PubMed
- [19] Amanda M Huskey et al.. Ann Pharmacother. 2013. Occurrence of milnacipran-associated morbilliform rash and serotonin toxicity. doi:10.1345/aph.1R474 PubMed
- [20] Joann E Manson et al.. Contemp Clin Trials. 2012. The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and … doi:10.1016/j.cct.2011.09.009 PubMed
- [21] Eka Ginanjar et al.. Acta Med Indones. 2007. Vitamin D and autoimmune disease. PubMed
- [22] Barbara J Messinger-Rapport et al.. J Am Med Dir Assoc. 2007. Intensive session: New approaches to medical issues in long-term care. doi:10.1016/j.jamda.2007.07.002 PubMed
- [23] Wen-Ching Chen et al.. Am J Kidney Dis. 2006. Sleep behavior disorders in a large cohort of chinese (Taiwanese) patients maintained by long-term hemodialysis. doi:10.1053/j.ajkd.2006.04.079 PubMed
- [24] P R Koninckx et al.. Maturitas. 1993. Endometrial effects during hormone replacement therapy with a sequential oestradiol valerate/cyproterone acetate preparation. doi:10.1016/0378-5122(93)90054-l PubMed
FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.